Novalis LifeSciences Investments II, L.P. — Form D/A
Novalis LifeSciences Investments II, L.P. of HAMPTON, NH, a pooled investment fund, filed a Form D amendment with the SEC on 2022-03-29. $296.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-03-29
- Form: D/A
- Accession: 0001890017-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Amount sold: $296.8M
- Investors: 51
- Date of first sale: 2021-10-29
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-418587
Issuer
- Name: Novalis LifeSciences Investments II, L.P.
- CIK: 0001890017
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1 LIBERTY LANE E, HAMPTON, NH, 03842
- Phone: 603-339-0084
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Marijn E Dekkers | Executive Officer | Cambridge, MA |
| PAUL E MEISTER | Executive Officer | HAMPTON, NH |
Other filings by this issuer (1)
More